Ferra Joseph J Jr has filed 27 insider transactions across 1 company since February 2024.
Most recent transaction: a option exercise of 12560 shares of Elevation Oncology, Inc. ($ELEV) on June 16, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 16, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Common Stock | 12560 | $0.00 | 149,712.0000 | 59,173,854 | 9.16% | 0.02% |
| June 16, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | F | Common Stock | 4627 | $0.39 | 145,085.0000 | 59,173,854 | 3.09% | 0.01% |
| June 16, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 12560 | $0.00 | 0.0000 | 59,173,854 | 100.00% | 0.02% |
| May 15, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Common Stock | 6250 | $0.00 | 139,455.0000 | 59,173,854 | 4.69% | 0.01% |
| May 15, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | F | Common Stock | 2303 | $0.30 | 137,152.0000 | 59,173,854 | 1.65% | 0.00% |
| May 15, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6250 | $0.00 | 68,750.0000 | 59,173,854 | 8.33% | 0.01% |
| March 16, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Common Stock | 12562 | $0.00 | 137,833.0000 | 57,275,454 | 10.03% | 0.02% |
| March 16, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | F | Common Stock | 4628 | $0.53 | 133,205.0000 | 57,275,454 | 3.36% | 0.01% |
| March 16, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 12562 | $0.00 | 12,560.0000 | 57,275,454 | 50.00% | 0.02% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Common Stock | 25000 | $0.00 | 134,482.0000 | 57,275,454 | 22.83% | 0.04% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | F | Common Stock | 9211 | $0.67 | 125,271.0000 | 57,275,454 | 6.85% | 0.02% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 800000 | $0.00 | 800,000.0000 | 57,275,454 | 9999.99% | 1.40% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 25000 | $0.00 | 75,000.0000 | 57,275,454 | 25.00% | 0.04% |
| Dec. 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Common Stock | 12563 | $0.00 | 114,111.0000 | 59,108,724 | 12.37% | 0.02% |
| Dec. 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | F | Common Stock | 4629 | $0.64 | 109,482.0000 | 59,108,724 | 4.06% | 0.01% |
| Dec. 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 12563 | $0.00 | 25,122.0000 | 59,108,724 | 33.34% | 0.02% |
| Sept. 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Common Stock | 12562 | $0.00 | 106,176.0000 | 54,578,340 | 13.42% | 0.02% |
| Sept. 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | F | Common Stock | 4628 | $0.61 | 101,548.0000 | 54,578,340 | 4.36% | 0.01% |
| Sept. 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 12562 | $0.00 | 37,685.0000 | 54,578,340 | 25.00% | 0.02% |
| June 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Common Stock | 12562 | $0.00 | 98,242.0000 | 51,811,882 | 14.66% | 0.02% |
| June 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | F | Common Stock | 4628 | $3.23 | 93,614.0000 | 51,811,882 | 4.71% | 0.01% |
| June 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 12562 | $0.00 | 50,247.0000 | 51,811,882 | 20.00% | 0.02% |
| March 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Common Stock | 12562 | $0.00 | 90,453.0000 | 36,522,716 | 16.13% | 0.03% |
| March 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | F | Common Stock | 4773 | $4.39 | 85,680.0000 | 36,522,716 | 5.28% | 0.01% |
| March 16, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 12562 | $0.00 | 62,809.0000 | 36,522,716 | 16.67% | 0.03% |
| Feb. 15, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 36,522,716 | 9999.99% | 1.64% |
| Feb. 15, 2024 | Elevation Oncology, Inc. | $ELEV | Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 36,522,716 | 9999.99% | 0.27% |